Lamotrigine monotherapy for newly diagnosed typical absence seizures in children

Epilepsy Research

Volumn 82, Issue 2-3, 2008, Pages 124-132

  Holmes, Gregory L ^a   Frank, L Matthew ^b   Sheth, Raj D ^c   Philbrook, Bryan ^d   Wooten, John D ^e   Vuong, Alain ^f   Kerls, Susan ^f   Hammer, Anne E ^f   Messenheimer, John ^f  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d Child Neurology Associates   (United States)

^e Raleigh Neurology Associates   (United States)

^f GLAXOSMITHKLINE   (United States)

Author keywords

Absence seizures; Antiepileptic drugs; Clinical trial

Indexed keywords

LAMOTRIGINE;

ABSENCE; ADOLESCENT; ANTICONVULSANT THERAPY; ARTICLE; CHILD; CHILD BEHAVIOR; CLINICAL TRIAL; CONSTIPATION; COUGHING; DIZZINESS; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; FEMALE; HEADACHE; HUMAN; HYPERVENTILATION; LIMB PAIN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NAUSEA; NOSE CONGESTION; PHARYNGITIS; PRIORITY JOURNAL; PRURITUS; RASH; RESTLESSNESS; RHINOPHARYNGITIS; SINUSITIS; SOCIAL PSYCHOLOGY; SORE THROAT; STOMACH DISCOMFORT; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PHARYNGITIS; TREATMENT OUTCOME; TREMOR; UPPER ABDOMINAL PAIN; URTICARIA; VIRAL GASTROENTERITIS; VOMITING;

ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; ELECTROENCEPHALOGRAPHY; EPILEPSY, ABSENCE; FEMALE; HEADACHE; HUMANS; MALE; MEDICAL RECORDS; MONITORING, AMBULATORY; TREATMENT OUTCOME; TRIAZINES;

EID: 56749185605     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2008.07.016     Document Type: Article

References (36)

1. Achenbach T.M. Integrative Guide to the 1991 CBCL/4-18, YSR, and TRF Profiles (1991), University of Vermont, Burlington
2. Adams D.J., and Lueders H. Hyperventilation and six-hour EEG recording in evaluation of absence seizures. Neurology 31 (1981) 1175-1177
3. Bird H.R., Canino G., Rubio-Stipec M., and Ribera J.C. Further measures of the psychometric properties of the Children's Global Assessment Scale. Arch. Gen. Psychiatry 44 (1987) 821-824
4. Brodbeck V., Jansen V., Fietzek U., Muehe C., Weber G., and Heinen F. Long-term profile of lamotrigine in 119 children with epilepsy. Eur. J. Paediatr. Neurol. 10 (2006) 135-141
5. Browne T.R., Dreifuss F.E., Penry J.K., Porter R.J., and White B.G. Clinical and EEG estimates of absence seizure frequency. Arch. Neurol. 40 (1983) 469-472
6. Browne T.R., Penry J.K., Porter R.J., et al. Responsiveness before, during, and after spike-wave paroxysms. Neurology 24 (1974) 659-665
7. Buoni S., Grosso S., and Fois A. Lamotrigine in typical absence epilepsy. Brain Dev. 21 (1999) 303-306
8. Coppola G., Auricchio G., Federico R., Carotenuto M., and Pascotto A. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study. Epilepsia 45 (2004) 1049-1053
9. Coppola G., Licciardi G., Sciscio N., Russo F., Carotenuto M., and Pascotto A. Lamotrigine as first-line drug in childhood absence epilepsy: a clinical and neurophysiological study. Brain Dev. 26 (2004) 26-29
10. Duchowny M., Gilman J., Messenheimer J., Womble G., and Risner M. Long-term tolerability and efficacy of lamotrigine in pediatric patients with epilepsy. J. Child Neurol. 17 (2002) 278-285
11. Ferrie C.D., Robinson R.O., Knott C., and Panayiotopoulos C.P. Lamotrigine as an add-on drug in typical absence seizures. Acta Neurol. Scand. 91 (1995) 200-202
12. Frank L.M., Enlow T., Holmes G.L., Manasco P., Concannon S., Chen C., Womble G., and Casale E.J. Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia 40 (1999) 973-979
13. Granleese J., and Joseph S. Reliability of the Harter self-perception profile for children and predictors of global self-worth. J. Genet. Psychol. 155 (1994) 487-492
14. Grosso S., Galimberti D., Vezzosi P., Farnetani M., di Bartolo R.M., Bazzotti S., Morgese G., and Balestri P. Childhood absence epilepsy: evolution and prognostic factors. Epilepsia 46 (2005) 1796-1801
15. Guberman A.H., Besag F.M., Brodie M.J., Dooley J.M., Duchowny M.S., Pellock J.M., Richens A., Stern R.S., and Trevathan E. Lamotrigine-associated rash: risk/benefit considerations in adults and children. Epilepsia 40 (1999) 985-991
16. Harter S. The Construction of the Self. A Developmental Perspective (1999), Guilford Publications, Inc., New York
17. Harter S. The Self-Perception Profile for Children: Revision of the Perceived Competence Scale for Children (1985), University of Denver, Denver, Colorado
18. Hirsch L.J., Weintraub D.B., Buchsbaum R., Spencer H.T., Straka T., Hager M., and Resor Jr. S.R. Predictors of lamotrigine-associated rash. Epilepsia 47 (2006) 318-322
19. Kluger G., Berz K., and Holthausen H. The long-term use of vigabatrin and lamotrigine in patients with severe childhood onset epilepsy. Eur. J. Paediatr. Neurol. 5 (2001) 37-40
20. Marson A.G., et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 369 (2007) 1016-1026
21. Messenheimer J.A. Rash in adult and pediatric patients treated with lamotrigine. Can. J. Neurol. Sci. 25 (1998) S14-S18
22. Panayiotopoulos C.P. Treatment of typical absence seizures and related epileptic syndromes. Paediatr. Drugs (2001) 379-403
23. Pearl P.L., and Holmes G.L. Absence seizures. In: Pellock J.M., Dodson W.E., and Bourgeois B.F.D. (Eds). Pediatric Epilepsy. Diagnosis and Treatment (2001), Demos, New York 219-231
24. Pearl P.L., and Holmes G.L. Childhood absence epilepsies. In: Pellock J.M., Bourgeois B.F.D., and Dodson W.E. (Eds). Pediatric Epilepsy (2008), Demos, New York 323-334
25. Penry J.K., Porter R.J., and Dreifuss F.E. Simultaneous recording of absence sizures with videotape and electroencephalography. Brain 98 (1975) 427-440
26. Porter R.J., Penry J.K., and Dreifuss F.E. Responsiveness at the onset of spike-wave bursts. Electroencephalogr. Clin. Neurophysiol. 34 (1973) 239-245
27. Posner E. Absence seizures in children. Clin. Evid. (2005) 221-226
28. Posner E. Pharmacological treatment of childhood absence epilepsy. Expert Rev. Neurother. 6 (2006) 855-862
29. Posner E.B., Mohamed K., and Marson A.G. A systematic review of treatment of typical absence seizures in children and adolescents with ethosuximide, sodium valproate or lamotrigine. Seizure 14 (2005) 117-122
30. Posner, E.B., Mohamed, K., Marson, A.G., 2005b. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Cochrane Database Syst. Rev. CD003032.
31. Shaffer D., Gould M.S., Brasic J., Ambrosini P., Fisher P., Bird H., and Aluwahlia S. A children's global assessment scale (CGAS). Arch. Gen. Psychiatry 40 (1983) 1228-1231
32. Tovia E., Goldberg-Stern H., Shahar E., and Kramer U. Outcome of children with juvenile absence epilepsy. J. Child Neurol. 21 (2006) 766-768
33. Wirrell E.C. Natural history of absence epilepsy in children. Can. J. Neurol. Sci. 30 (2003) 184-188
34. Wirrell E.C., Camfield C.S., Camfield P.R., Dooley J.M., Gordon K.E., and Smith B. Long-term psychosocial outcome in typical absence epilepsy. Sometimes a wolf in sheeps' clothing. Arch. Pediatr. Adolesc. Med. 151 (1997) 152-158
35. Wirrell E.C., Camfield C.S., Camfield P.R., Gordon K.E., and Dooley J.M. Long-term prognosis of typical childhood absence epilepsy: remission or progression to juvenile myoclonic epilepsy. Neurology 47 (1996) 912-918
36. Wirrell E.C., Camfield P.R., Camfield C.S., Dooley J.M., and Gordon K.E. Accidental injury is a serious risk in children with typical absence epilepsy. Arch. Neurol. 53 (1996) 929-932